Skip to main navigation Skip to search Skip to main content

NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025

  • Timothy Gilligan
  • , Daniel W. Lin
  • , Nabil Adra
  • , Aditya Bagrodia
  • , Darren R. Feldman
  • , Kosj Yamoah
  • , Rahul Aggarwal
  • , Thenappan Chandrasekar
  • , Daniel Costa
  • , Alexandra Drakaki
  • , Scott Eggener
  • , Hamid Emamekhoo
  • , Daniel M. Geynisman
  • , Laura Graham
  • , Peter Humphrey
  • , Harshraj Leuva
  • , Ellis G. Levine
  • , Amy Luckenbaugh
  • , Benjamin L. Maughan
  • , Bradley McGregor
  • Paul Monk, Joel Picus, Phillip Pierorazio, Soroush Rais-Bahrami, Zachery Reichert, Jean Claude Rwigema, Philip Saylor, Ankeet Shah, Sumit Shah, Nirmish Singla, Kanishka Sircar, David VanderWeele, Ali Zhumkhawala, Sarah Montgomery, Bailee Sliker
  • Case Western Reserve University
  • Fred Hutchinson Cancer Research Center
  • Indiana University Bloomington
  • University of California at San Diego
  • Memorial Sloan-Kettering Cancer Center
  • Moffitt Cancer Center
  • University of California at San Francisco
  • University of California at Davis
  • UT Southwestern Simmons Comprehensive Cancer Center
  • University of California at Los Angeles
  • University of Chicago
  • University of Wisconsin-Madison
  • University of Colorado Anschutz Medical Campus
  • Yale University
  • University of Nebraska Medical Center
  • Roswell Park Comprehensive Cancer Center
  • Vanderbilt University
  • University of Utah
  • Dana-Farber/Brigham and Women's Cancer Center
  • Ohio State University
  • Washington University St. Louis
  • University of Pennsylvania
  • University of Alabama at Birmingham
  • University of Michigan, Ann Arbor
  • Mayo Clinic
  • Mass General Cancer Center
  • Duke University
  • Stanford University
  • Johns Hopkins University
  • University of Texas MD Anderson Cancer Center
  • Northwestern University
  • City of Hope National Medical Center
  • National Comprehensive Cancer Network

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

The NCCN Guidelines for Testicular Cancer provide recommendations for the multidisciplinary approach to the diagnostic workup, treatment, and follow-up for testicular germ cell tumors, including both seminoma and nonseminoma. These NCCN Guidelines Insights discuss the current treatment recommendations and supporting clinical data for seminomas as presented in Version 2.2025 of the NCCN Guidelines for Testicular Cancer.

Original languageEnglish
Article numbere250018
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume23
Issue number4
DOIs
StatePublished - Apr 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Humans
  • Male
  • Medical Oncology/standards
  • Neoplasm Staging
  • Neoplasms, Germ Cell and Embryonal/therapy
  • Seminoma/therapy
  • Testicular Neoplasms/therapy

Fingerprint

Dive into the research topics of 'NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025'. Together they form a unique fingerprint.

Cite this